SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-20-003483
Filing Date
2020-03-12
Accepted
2020-03-12 16:55:34
Documents
85
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rgls20191231-10k.htm 10-K 1543175
2 EXHIBIT 4.3 a201910kex-43xdescriptiono.htm EX-4.3 31536
3 EXHIBIT 23.1 a201910kex-231xconsentofin.htm EX-23.1 4380
4 EXHIBIT 31.1 a201910kex-311xcertofprinc.htm EX-31.1 12075
5 EXHIBIT 31.2 a201910kex-312xcertofprinc.htm EX-31.2 12051
6 EXHIBIT 32.1 a201910kex-321xcertpursuan.htm EX-32.1 11703
13 bussectionpipelineslidea02.jpg GRAPHIC 41894
  Complete submission text file 0001628280-20-003483.txt   7603502

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgls-20191231.xml EX-101.INS 1303631
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20191231.xsd EX-101.SCH 61036
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20191231_cal.xml EX-101.CAL 97103
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20191231_def.xml EX-101.DEF 321110
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20191231_lab.xml EX-101.LAB 847985
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20191231_pre.xml EX-101.PRE 485536
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35670 | Film No.: 20709534
SIC: 2834 Pharmaceutical Preparations